Skip to content
Clinical Trials for Alzheimer's Disease

Daytona Beach, Florida

Alzheimer's disease clinical trials in Daytona Beach, FL

8 Alzheimer's disease studies are recruiting participants at sites in Daytona Beach as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Daytona Beach at a glance

  • 8 studies are recruiting at a site in Daytona Beach.
  • By phase: Phase 1 (2), Phase 2 (1), Phase 2/3 (1), Phase 3 (4).
  • By sponsor: industry (8).
  • Most recent update to one of these records: November 12, 2026.

Studies recruiting in Daytona Beach

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Arrow Clinical Trials
    Registry record
    NCT05980949 · updated
  2. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Study site
    Arrow Clinical Trials
    Registry record
    NCT06159673 · updated
  3. A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

    • Phase 1
    • Ages 18 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Fortrea Clinical Research Unit
    Registry record
    NCT07787169 · updated
  4. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    K2 Medical Research - Daytona Beach
    Registry record
    NCT07602582 · updated
  5. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Arrow Clinical Trials
    Registry record
    NCT06585787 · updated
  6. A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

    • Phase 1
    • Ages 18 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Fortrea Clinical Research Unit
    Registry record
    NCT07787182 · updated
  7. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Study site
    Arrow Clinical Trials
    Registry record
    NCT06808984 · updated
  8. A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Arrow Clinical Trials
    Registry record
    NCT05511363 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Daytona Beach, FL on ClinicalTrials.gov.

Ask about studies near Daytona Beach

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call